Latanotim-Vision Sine (Timolol Maleate, Latanoprost)

Timolol maleate blocks beta‑adrenergic receptors in the eye, reducing the production of aqueous humor. Latanoprost mimics prostaglandin F2α, binding to FP receptors and increasing uveoscleral outflow of fluid. Together they provide a complementary mechanism that lowers eye pressure effectively.

The dosing regimen for Latanotim-Vision Sine is determined by the prescribing clinician based on the individual’s condition and response. Typically, one drop is instilled in the affected eye(s) once daily, but the exact schedule should follow the healthcare provider’s instructions.

Safety data for timolol maleate and latanoprost during pregnancy or lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant. Patients should discuss their situation with a qualified healthcare professional.

To request Latanotim-Vision Sine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with monotherapy options, the timolol‑latanoprost combination offers dual pressure‑lowering mechanisms in a single drop, often achieving greater IOP reduction than either agent alone. This can simplify treatment regimens and improve adherence, while maintaining a safety profile similar to the individual components.

Latanotim-Vision Sine should be stored at room temperature, protected from light and moisture. Keep the bottle tightly closed when not in use. Do not freeze the product, and discard any solution that appears discolored or contains particles.

The medication is applied as an eye drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid to form a pocket, and place one drop into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few seconds.

Serious adverse events include severe allergic reactions such as swelling or difficulty breathing, marked bradycardia or hypotension, and bronchospasm in patients with asthma or COPD. Any sudden visual changes, eye pain, or systemic symptoms should prompt immediate medical evaluation.

Patients with known hypersensitivity to timolol, latanoprost, or any component of the formulation should avoid the product. Individuals with severe sinus node dysfunction, uncontrolled asthma, or certain cardiac conduction disorders should not use it without close medical supervision.